KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hologic (HOLX) EBIT (2016 - 2025)

Historic EBIT for Hologic (HOLX) over the last 17 years, with Q4 2025 value amounting to $237.0 million.

  • Hologic's EBIT rose 313.32% to $237.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $721.5 million, marking a year-over-year decrease of 2107.85%. This contributed to the annual value of $714.3 million for FY2025, which is 1906.87% down from last year.
  • Per Hologic's latest filing, its EBIT stood at $237.0 million for Q4 2025, which was up 313.32% from $236.9 million recorded in Q3 2025.
  • In the past 5 years, Hologic's EBIT registered a high of $796.8 million during Q1 2021, and its lowest value of -$7.0 million during Q1 2025.
  • Its 5-year average for EBIT is $286.9 million, with a median of $240.5 million in 2024.
  • Its EBIT has fluctuated over the past 5 years, first surged by 1732857.14% in 2024, then plummeted by 10332.7% in 2025.
  • Over the past 5 years, Hologic's EBIT (Quarter) stood at $641.3 million in 2021, then tumbled by 59.08% to $262.4 million in 2022, then fell by 24.47% to $198.2 million in 2023, then grew by 15.94% to $229.8 million in 2024, then increased by 3.13% to $237.0 million in 2025.
  • Its EBIT stands at $237.0 million for Q4 2025, versus $236.9 million for Q3 2025 and $254.6 million for Q2 2025.